Canadian HTA Assessments Recognize Therapeutic Value of QALSODY™ (tofersen injection) and its Potential to Modify Disease Progression in Individuals Living with SOD1-ALS

— CDA issues positive reimbursement recommendation for QALSODY — INESSS recognizes QALSODY's promising clinical value and highlights path toward reimbursement — HTA assessments highlight importance of timely and equitable access to QALSODY for this ultra-rare genetic form of ALS and urgent need for therapies that slow progression, preserve function and independence, extend survival, and improve […]

Canada Forestry and Lumber Trade Update: to August 2025

Log exports from Canada dropped -15% so far this year compared to 2024, while lumber exports rose +1.6%. Since 1952 Madison's Lumber Reporter has established itself as the most reliable source for North American lumber prices and forest industry news. We understand that the market responds to a variety of inputs. By providing a true

AquaBoréal is included in the Northern Action Plan 2023‑2028 of the Gouvernement du Québec

Financial support from the Ministère de l'Agriculture, des Pêcheries et de l'Alimentation (MAPAQ) to boost a flagship northern aquaculture project. AquaBoréal reaches an important milestone in its development. The Québec-based company will receive financial support from the Gouvernement du Québec in the framework of the Northern Action Plan 2023-2028 to develop production, processing and marketing

USA Forestry and Lumber Trade Update: to August 2025

Log exports from USA to the world dropped -27% so far this year compared to 2024, and lumber exports fell almost -9%. Since 1952 Madison's Lumber Reporter has established itself as the most reliable source for North American lumber prices and forest industry news. We understand that the market responds to a variety of inputs.

ARE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alexandria Real Estate Equities, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / December 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. ("Alexandria" or "the Company") (NYSE:ARE) and certain of its officers. Class Definition This lawsuit seeks to recover

Asante Provides Financial and Operating Results for the Quarter Ended October 31, 2025

Asante Provides Financial and Operating Results for the Quarter Ended October 31, 2025 GlobeNewswire December 11, 2025 VANCOUVER, British Columbia, Dec. 11, 2025 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSX-V:ASE | GSE:ASG | OTCQX:ASGOF) (“Asante” or the “Company”) announces the filing of its financial statements and management's discussion and analysis (“MD&A”) for the three months

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio GlobeNewswire December 11, 2025 NEW YORK and AMSTERDAM, Dec. 11, 2025 (GLOBE NEWSWIRE) — Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments,

YSX TECH. CO., LTD Relocates Research and Development Center to Expanded Facility

YSX TECH. CO., LTD Relocates Research and Development Center to Expanded Facility GlobeNewswire December 11, 2025 GUANGZHOU, China, Dec. 11, 2025 (GLOBE NEWSWIRE) — YSX TECH. CO., LTD (NASDAQ: “YSXT”) (the “Company”), a Cayman Islands exempted company that, through its variable interest entities in China, provides comprehensive business solutions mainly for insurance companies and brokerages

Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics

Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics GlobeNewswire December 11, 2025 Chaired by globally renowned nuclear medicine expert Prof. Ken Herrmann, M.D. Other Board members James Cook, Jason Lewis, Ph.D., and Michael Morris, M.D. bring significant clinical and industry expertise, supporting transition from early clinical validation to strategic development ZURICH-SCHLIEREN,

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025 GlobeNewswire December 11, 2025 Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens Transcriptomic analysis across ~11,000 TCGA

Scroll to Top